Information Collection Request

Arrestee Drug Abuse Monitoring (ADAM II)

ICR 201301-3201-007 · OMB 3201-0016 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
2013 ADAM OMB Institutional_Review_Board_Notice_of_Approval_study_modification(12).pdf Supplementary Document Uploaded 2013-01-11 Available
2013 ADAM OMB Technical Documentation Report 2012.docx Supplementary Document Uploaded 2013-01-11 Available
2013 ADAM OMB facesheet 2012.pdf Supplementary Document Uploaded 2013-01-11 Available
2013 ADAM OMB certificf of conf 2011.pdf Supplementary Document Uploaded 2013-01-11 Repair queued
2013 ADAM OMB ADAM instrument.pdf Supplementary Document Uploaded 2013-01-11 Available
ADAMIII_OMB Part B revised 2012.docx Supporting Statement B Uploaded 2013-05-01 Available
ADAMII_OMB Part A_edited.docx Supporting Statement A Uploaded 2013-05-01 Available
IC Document Collections
IC IDCollectionTypeStatusForm
191750 Arrestee Drug Abuse Monitoring (ADAM II) Other-null Modified
ICR Details
3201-0016 201301-3201-007
Historical Active 201001-3201-002
ONDCP
Arrestee Drug Abuse Monitoring (ADAM II)
Revision of a currently approved collection   No
Regular
Approved with change 05/02/2013
Retrieve Notice of Action (NOA) 03/26/2013
This collection is approved conditional on the following terms: 1. The agency will clearly indicate that estimates yielded from this study are representative of adult males in selected counties physically able to give informed consent within the 24 hours of their arrest (the study is not nationally or regionally representative); and 2. Should the ADAM study be extended, the agency will meet with OIRA to discuss proposed sampling design in advance of providing notice in the Federal Register.
  Inventory as of this Action Requested Previously Approved
05/31/2014 36 Months From Approved 05/31/2013
1,750 0 5,000
765 0 1,853
0 0 1,653,540

A purposive, non-probability sample of sentinel sights (not representative of the US as a whole or individual states or other areas that were not surveyed) that replicates the ADAM methodology in order to obtain data comparable to previously established trends in 5 of the prior ADAM sites. ADAM II implements one quarter of data collection in five sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use.

None
None

Not associated with rulemaking

  78 FR 12 01/17/2013
78 FR 58 03/26/2013
No

1
IC Title Form No. Form Name
Arrestee Drug Abuse Monitoring (ADAM II)

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,750 5,000 0 -3,250 0 0
Annual Time Burden (Hours) 765 1,853 0 -1,088 0 0
Annual Cost Burden (Dollars) 0 1,653,540 0 0 -1,653,540 0
No
Yes
Miscellaneous Actions
The number of sites were reduced to 5 and the number of quarters reduced to 1 due to budget limitations. To ensure sufficient samples were collected in the ramining sites to enable annual estimations, the number of weeks for data collection were increased from 2 to 3. The annual cost burden was reduced to zero because it consisted of labor costs that were already accounted for in the Annual Time Burden (Hr) column.

$677,996
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Terry Zobeck 202 395-5503

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/26/2013